# \[e-med\] Field Testing d'un pack antirétroviral de prévention mère-enfant **URL:** \ **Category:** e-med\ **Created:** [December 30, 2009, 2:10pm UTC](https://talk.edrugplus.org/t/e-med-field-testing-dun-pack-antiretroviral-de-prevention-mere-enfant/33014 "2009-12-30T14:10:58Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![Tifenn\_Humbert](https://avatars.discourse-cdn.com/v4/letter/t/7bcc69/32.png) [@Tifenn\_Humbert](https://talk.edrugplus.org/u/Tifenn_Humbert)\ **Post date:** [December 30, 2009, 2:10pm UTC](https://talk.edrugplus.org/t/e-med-field-testing-dun-pack-antiretroviral-de-prevention-mere-enfant/33014/1 "2009-12-30T14:10:58Z")
Chers Collegues, En raison des fetes de fin d'année, UNICEF a decidé de prolonger le delais de submission de la demande d'expression d'interet ci-dessous jusqu'au 15 Janvier 2010. ----- Forwarded by Tifenn Humbert/DAN/HQ/UNICEF on 30/12/2009 15:06 ----- Tifenn Humbert/DAN/HQ/UNICEF 17/12/2009 17:21 To e-med@healthnet.org cc Subject EXPRESSION OF INTEREST (EOI) - Reference EOI-MBP Field Testing Phase 2(UNICEF) Dans le cadre du developpement du Mother-Baby Pack (MBP) pour la PTME (Prevention de la Transmission de la Mere a l'Enfant du VIH), l'UNICEF diffuse la demande d'expression d'interet suivante: UNITED NATIONS CHILDREN'S FUND (UNICEF) EXPRESSION OF INTEREST (EOI) - Reference EOI-MBP Field Testing Date of the EOI: 18 December 2009 Closing Date of the EOI: 8 January 2010 Address EOI by e-mail to: Ms. Tifenn Humbert at thumbert@unicef.org TERMS OF REFERENCE UNICEF Supply Division welcomes eligible institutions to submit an expression of interest to undertake field testings of the Mother-Baby Pack, an innovative simple, user-friendly and affordable packaged mechanism to deliver prophylactic antiretroviral (ARV) regimens for the prevention of mother-to-child transmission (PMTCT) of HIV. 1. Background and Project Summary In 2008, 45% of pregnant women living with HIV in low-and middle-income countries received antiretroviral drugs to prevent HIV transmission to their infants, including antiretroviral therapy for their own health Toward Universal Access. Scaling up HIV services for women and children in the health sector. Progress report 2009.. Indeed, PMTCT coverage is still quite low globally and national programmes are facing various challenges translating the WHO guidelines PMTCT Antiretroviral medicines for treating pregnant women and preventing HIV infection in infants: toward universal access [http://www.who.int/hiv/pub/mtct/pmtct/en/](http://www.who.int/hiv/pub/mtct/pmtct/en/) into actions. This is mainly attributable to weak health systems, frequent stockouts of medicines, social and cultural obstacles, and many PMTCT candidates are missed or do not get the full complement of medicines they need. UNICEF in collaboration with WHO and global partners supporting PMTCT and paediatric HIV care, support and treatment is developing an innovative simple, user-friendly and affordable package mechanism to deliver PMTCT prophylactic medications, the Mother-Baby Pack (MBP). The MBP contains medicines for prophylaxis, ARVs and Cotrimoxazole, for the mother and for the infant in line with WHO PMTCT Guidelines (2006) and new recommendations from November 2009. 2. Purpose of MBP The MBP is an innovative product aimed to facilitate the scale-up and increased uptake of more efficacious ARV prophylactic regimens for PMTCT (combination of Zidovudine and Single-dose Nevirapine) and Cotrimoxazole prophylaxis in resource-limited settings in line with 2006 WHO Treatment guidelines and new WHO recommendations from November 2009. The MBP also intends to help streamline the procurement and supply management of PMTCT prophylactic medicines. The initiative takes into consideration limited capacities of health care systems (institutional and human), operational management including tracking and follow-up mechanisms for a continuum of care, as well as the health seeking behaviours of clients. 3. Project Requirements The full pack is intended to be distributed within ANC clinics to HIV-positive pregnant woman, ideally at the first ANC visit from week 14 of pregnancy or at the earliest opportunity thereafter. Moreover, some pregnant women may come later (up to 40 weeks of pregnancy). The MBP will be also distributed through maternity/delivery facilities to target women presenting for the first time to the health facility at labour and also for those seen during pregnancy who received a MBP but will not bring their pack at the time of delivery. The MBP is designed to be used both within and outside the clinical setting. It is intended to be user-friendly, manageable, and water-resistant. It includes the principal PMTCT commodities in their basic unit packaging to allow for flexibility of dispensing and administration to patient. The objective of the proposed assignment for which UNICEF invites EOIs is to facilitate the field testing of the Mother-Baby Pack inclusive of its contents and packaging in the context of PMTCT Programmes, and to provide performance (effectiveness) and management (efficiency) feedback to the Mother Baby Pack Technical Working Group with the intention to contribute to strengthening the effectiveness of the pack itself and its potential impact on scale-up and increased uptake of more efficacious ARV prophylactic regimens for PMTCT. Under the overall guidance of UNICEF and as informed by the Mother Baby Pack Technical Working Group, the selected institution is expected to work together with the stakeholders via the UNICEF Project Manager in field-testing the prototype. The field testing of the MBP will be conducted in selected African countries. These field trials are important as it will assess the introduction of the full MBP (inclusive of its contents) and will measure its impact on PMTCT uptake. During this process, issues related to stigma, adherence, supply chain and programmatic issues will be taken into consideration. Following the Expression of Interest, UNICEF expects to issue Requests for Proposals (RFP) in the first quarter of 2010 to all qualified entities who had submitted EOIs and to other interested institutions. SUBMISSION OF EXPRESSION OF INTEREST (EOI) Interested institutions are encouraged to complete and submit below EOI form. EOIs should be sent to Ms. Tifenn Humbert, e-mail: thumbert@unicef.org, not later than 8th January 2010. Please quote ?EOI ? MBP Field Testing as subject in your correspondence. This EOI does not constitute a solicitation. We do not require bids or proposals at this stage; we merely seek your expression of interest in participating in the tender. A response to this Request for Expression of Interest does not automatically ensure that you will be selected to participate in the tender. UNICEF reserves the right to change or cancel the requirement at any time during the EOI and/or solicitation process. UNICEF also reserves the right to require compliance with additional conditions as and when issuing the final tender document. If you have any additional question about this EOI, please contact Ms. Tifenn Humbert, e-mail: thumbert@unicef.org. EXPRESSION OF INTEREST FORM (EOI form) - Reference EOI-MBP Field Testing [Please check the box when appropriate] GENERAL INFORMATION Full company name: Manufacturer: Trader: Service provider: Address: Country: Contact Person: E-mail address: Tel: Fax: Alternative Contact person: E-mail address: INTEREST IN SUPPLYING THE FOLLOWING SERVICE[S] Yes No Quantitative & qualitative research on HIV/AIDS scale-up efforts. Training of health service providers. Survey and research analysis. Procurement and supply chain management. QMS [Specify QMS required] If others, please specify ADDITIONAL INFORMATION Company established in? (year) Registration as legal entity in?(country) Years of experience providing similar goods/service(s) Registration with UNGM www.ungm.org If so, registration number: On completion, return this form to UNICEF by email to Tifenn Humbert ( thumbert@unicef.org) on or before 8 January 2010.